Update on aurora kinase inhibitors in gynecologic malignancies
- PMID: 18991785
- PMCID: PMC3039426
- DOI: 10.2174/157489208786242322
Update on aurora kinase inhibitors in gynecologic malignancies
Abstract
Aurora kinases are essential for the regulation of chromosome segregation and cytokinesis during mitosis and play a role in tumorigenesis and tumor progression in humans. Aurora kinase A and Aurora kinase B are overexpressed in some gynecologic cancers, and their overexpression is associated with poor prognosis. Thus, targeting of Aurora kinases has become an attractive strategy for pharmaceutical companies, who have developed more than 30 Aurora kinase inhibitors for treatment of cancers. Some of these inhibitors have been shown to be effective in targeted therapies for human cancer, and others are currently being investigated. In this review, we summarize the most recent advances in preclinical studies and clinical trials of patented Aurora kinase inhibitors for gynecologic tumors.
Figures
Similar articles
-
Aurora kinase inhibitors--rising stars in cancer therapeutics?Mol Cancer Ther. 2010 Feb;9(2):268-78. doi: 10.1158/1535-7163.MCT-09-0765. Epub 2010 Feb 2. Mol Cancer Ther. 2010. PMID: 20124450 Free PMC article. Review.
-
Aurora kinases as anticancer drug targets.Clin Cancer Res. 2008 Mar 15;14(6):1639-48. doi: 10.1158/1078-0432.CCR-07-2179. Clin Cancer Res. 2008. PMID: 18347165 Review.
-
Aurora A and B kinases--targets of novel anticancer drugs.Recent Pat Anticancer Drug Discov. 2010 Nov;5(3):219-41. doi: 10.2174/157489210791760517. Recent Pat Anticancer Drug Discov. 2010. PMID: 20524930 Review.
-
Aurora kinase inhibitors as anticancer molecules.Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):829-39. doi: 10.1016/j.bbagrm.2010.09.004. Epub 2010 Sep 20. Biochim Biophys Acta. 2010. PMID: 20863917 Free PMC article. Review.
-
Aurora-B kinase inhibitors for cancer chemotherapy.Mini Rev Med Chem. 2008 Dec;8(14):1514-25. doi: 10.2174/138955708786786480. Mini Rev Med Chem. 2008. PMID: 19075809 Review.
Cited by
-
PUF60/AURKA Axis Contributes to Tumor Progression and Malignant Phenotypes in Bladder Cancer.Front Oncol. 2020 Oct 7;10:568015. doi: 10.3389/fonc.2020.568015. eCollection 2020. Front Oncol. 2020. PMID: 33117697 Free PMC article.
-
Analysis of genetic copy number changes in cervical disease progression.BMC Cancer. 2010 Aug 16;10:432. doi: 10.1186/1471-2407-10-432. BMC Cancer. 2010. PMID: 20712890 Free PMC article.
References
-
- World cancer report. 2008. [accessed October 8, 2010]. http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/wcr_2008.pdf.
-
- The global economic cost of cancer. [accessed October 8, 2010]. http://www.cancer.org/acs/groups/content/@internationalaffairs/documents....
-
- Carmena M, Earnshaw WC. The cellular geography of aurora kinases. Nat Rev Mol Cell Biol. 2003;4:842–54. - PubMed
-
- Ducat D, Zheng Y. Aurora kinases in spindle assembly and chromosome segregation. Exp Cell Res. 2004;301:60–7. - PubMed
-
- Marumoto T, Zhang D, Saya H. Aurora A, a guardian of poles. Nat Rev Cancer. 2005;5:42–50. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous